Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Reversion-Inducing-Cysteine-Rich Protein with Kazal Motifs (RECK) (Middle Region) Peptide

RECK Reactivité: Humain Hôte: Synthetic BP, WB
N° du produit ABIN5513994

Aperçu rapide pour Reversion-Inducing-Cysteine-Rich Protein with Kazal Motifs (RECK) (Middle Region) Peptide (ABIN5513994)

Antigène

RECK (Reversion-Inducing-Cysteine-Rich Protein with Kazal Motifs (RECK))

Origine

Humain

Source

  • 2
Synthetic

Application

Blocking Peptide (BP), Western Blotting (WB)
  • Protein Region

    Middle Region

    Séquence

    GSIICKSDCV EILKKCGDQN KFPEDHTAES ICELLSPTDD LKNCIPLDTY

    Attributs du produit

    This is a synthetic peptide designed for use in combination with anti-RECK Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
  • Indications d'application

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Stock

    -20 °C

    Stockage commentaire

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Antigène

    RECK (Reversion-Inducing-Cysteine-Rich Protein with Kazal Motifs (RECK))

    Sujet

    The protein encoded by this gene is a cysteine-rich, extracellular protein with protease inhibitor-like domains whose expression is suppressed strongly in many tumors and cells transformed by various kinds of oncogenes. In normal cells, this membrane-anchored glycoprotein may serve as a negative regulator for matrix metalloproteinase-9, a key enzyme involved in tumor invasion and metastasis.

    Alias Symbols: RECK,ST15,

    Protein Size: 971

    ID gène

    8434

    NCBI Accession

    NP_066934

    UniProt

    O95980
Vous êtes ici:
Chat with us!